Why NAD+ Matters (Especially After 40) NAD+ powers your mitochondria the batteries of every cell in your body

Plaintiffs in Ozempic litigation report injuries that have substantially impacted their health and quality of life: Gastroparesis (stomach paralysis) causing severe vomiting, inability to digest food properly, and malnutrition requiring feeding tubes Non-arteritic anterior ischemic optic neuropathy (NAION) resulting in sudden, permanent vision loss affecting one or both eyes Ileus and intestinal obstruction requiring emergency hospitalization and surgical procedures Severe gastrointestinal complications including bowel perforation and chronic digestive dysfunction Gallbladder disease necessitating surgical removal Aspiration pneumonia from persistent vomiting and impaired gastric emptying Gastroparesis affects approximately 4% of the population, but studies show that patients with definite gastroparesis have a 5-year survival rate of only 67% considerably lower than the 81% expected survival rate in the general population

Weight loss from GLP-1 therapy reduces the metabolic burden on kidneys, while improved glucose control decreases glycemic stress on renal tissue, and lower blood pressure reduces glomerular hyperfiltration
Higher doses and longer duration of GLP-1 RAs treatment were also associated with increased risk of gallbladder or biliary diseases, although the association was not statistically significant
For cell cycle analysis 10 6 cells/condition were fixed and permeabilized with cold 70% ethanol
GLP-1 Medications for Weight Loss: How to Get Started